Biotec Pharmacon of Tromsø, Norway, has been awarded US Patent No. 8,551,753, "Method of removing nucleic acid contamination in reverse transcription and amplification reactions."
Olav Lanes, Morten Elde, and Dag Rune Gjellesvik are named as inventors.
